Avenciguat: a novel soluble guanylate cyclase activator that affects multiple cell types to inhibit IFN-1 signalling and fibrosis. [PDF]
Kaufman J +11 more
europepmc +1 more source
Catalytic region mimetics in Na+/H+ exchanger regulatory factor 4 suppress guanylate cyclase 2C activity to regulate enterotoxin triggered diarrhea. [PDF]
Ramananda Y +6 more
europepmc +1 more source
Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase. [PDF]
Sharma A +8 more
europepmc +1 more source
Guanyl cyclase in a mammalian photoreceptor [PDF]
Goridis, C. +3 more
openaire +2 more sources
Editorial: Ferid murad, at 80: A legacy of science, medicine, and mentorship [PDF]
Atta-Ur-Rahman,
core +1 more source
Allosteric Communication of the Dimerization and the Catalytic Domain in Photoreceptor Guanylate Cyclase. [PDF]
Shahu MK +4 more
europepmc +1 more source
Soluble Guanylate Cyclase Stimulator, BAY41-8543: A Promising Approach for the Treatment of Chronic Heart Failure Caused by Pressure and Volume Overload. [PDF]
Martišková A +8 more
europepmc +1 more source
Hemoglobin resident in the lung epithelium is protective for smooth muscle soluble guanylate cyclase function. [PDF]
Sumi MP +7 more
europepmc +1 more source
The role of atrial natriuretic peptide (ANP) in chronic liver disease. [PDF]
Almeida +82 more
core +1 more source
The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial. [PDF]
Gansevoort RT +9 more
europepmc +1 more source

